Sewage Surveillance: India Sets 48-Hour Reporting Rule to Detect Disease Outbreaks Early
India's new sewage surveillance guidelines mandate laboratories to report findings within 48 hours, enabling authorities to detect viruses, bacteria and potential disease outbreaks before they appear in clinical data.
The Central Government on Monday issued uniform national guidelines for collecting and testing wastewater samples across the country. Under the new framework, laboratories will be required to upload their findings to India's existing disease surveillance platform within 48 hours of completing the tests. The system is expected to identify disease-causing viruses and bacteria one to two weeks before they appear in clinical data.
Titled ‘National Guidelines on Wastewater Surveillance for Monitoring Pathogens of Public Health Importance’, the document has been jointly prepared by the National Centre for Disease Control (NCDC) and the Alliance for Pathogen Surveillance Innovations (APSI)-India Consortium. Dr Rakesh Gupta, Additional Secretary (Public Health) in the Ministry of Health and Family Welfare, released the guidelines.
The guidelines establish standardised procedures for collecting sewage samples, conducting laboratory tests, interpreting findings and sharing information with the government's disease surveillance network.
The ministry said, “These guidelines are an important step towards strengthening wastewater-based surveillance for early detection of pathogens, monitoring disease trends and enabling timely public health interventions.”
The new framework aims to bring together wastewater surveillance activities that have so far been conducted independently by different institutions and research groups. It proposes a uniform system for monitoring infections across different communities by detecting pathogens that enter sewage through infected individuals, including those experiencing mild symptoms or those who do not seek medical attention.
India has previously used wastewater surveillance, particularly to monitor the spread of the poliovirus. Environmental surveillance of sewage began in Mumbai in 2001 and was subsequently expanded to other locations as a supplement to the country's Acute Flaccid Paralysis surveillance programme.
The usefulness of this approach also became evident during the COVID-19 pandemic, when research institutions and government agencies monitored SARS-CoV-2 infections through wastewater samples. During this period, several institutions, including the National Centre for Disease Control, Department of Biotechnology, Department of Science and Technology, Council of Scientific and Industrial Research and Indian Council of Medical Research, standardised testing procedures.
However, these initiatives primarily focused on specific pathogens or individual programmes. The new guidelines aim to establish a comprehensive national framework that can be used to monitor multiple infectious diseases and emerging public health threats.
The document identifies poliovirus, SARS-CoV-2, influenza, respiratory syncytial virus, measles, hepatitis A and E, dengue and cholera as potential priority pathogens for surveillance. It also proposes monitoring antimicrobial resistance (AMR) genes in wastewater and developing methods to detect unknown pathogens with the potential to cause epidemics.
Under the new guidelines, sewage samples can be collected from sewage treatment plants, sewer networks, open drains and wastewater outlets from hospitals. The selection of sampling locations will depend on local sanitation systems, the population covered by surveillance and the pathogens being monitored.
In large cities, sewer networks can be divided into different zones, with each zone covering a population of approximately 100,000 to 300,000 people. The guidelines caution against collecting samples from areas dependent on septic tanks, private toilets or open defecation grounds, as these sources may not provide samples that accurately represent a defined population.
Samples will be collected regularly, either weekly or once every 15 days. Laboratories must upload their findings to the Integrated Health Information Platform (IHIP) under the Integrated Disease Surveillance Programme (IDSP) within 48 hours of completing the tests. They will be required to meet this reporting deadline in at least 80 per cent of cases over a year.
The guidelines also prescribe faster reporting in certain situations, including the detection of a serious pathogen in an area where it has not previously been identified. An increase in pathogen levels across two consecutive sampling rounds or the identification of a new variant through sequencing will also require faster reporting.
Authorities will use the findings to identify potential disease outbreaks at an early stage and initiate appropriate responses. An increase in pathogen levels could trigger testing through mobile testing vans and fever clinics. Hospitals may also be asked to prepare by ensuring adequate availability of beds, oxygen supplies and medicines.
The guidelines further propose targeted vaccination campaigns in specific areas, identification of infection hotspots through GIS mapping and measures to prevent further disease transmission. If waterborne pathogens are detected, authorities may initiate water quality testing, check chlorine levels and repair leaking water and sewer pipelines.
The framework also proposes using wastewater surveillance to monitor antimicrobial resistance (AMR), a condition in which pathogens become less susceptible to medicines. Laboratories will test samples for genes responsible for resistance to antibiotic drugs.
Samples collected from the initial sections of sewage treatment plants will be used to monitor antimicrobial resistance in communities. Meanwhile, wastewater discharged from hospitals will be tested to identify the situation at an early stage within healthcare facilities.
These findings could help authorities track patterns of drug resistance, identify potential hotspots and prioritise testing and infection prevention measures. However, the guidelines describe this application as being ‘largely conceptual’ at present. They state that most available evidence comes from early projects and proof-of-concept studies.
According to the document, there are currently no documented examples in which routine wastewater surveillance of AMR has consistently helped trigger public health interventions.
The guidelines also caution that resistance genes can enter sewage through animal faeces and other environmental sources. Therefore, their presence does not necessarily indicate that people living in the area have infections involving drug-resistant pathogens.
The document makes it clear that wastewater testing cannot identify infected individuals or establish the exact number of patients in a community. Pathogen levels may fluctuate depending on rainfall, sewage flow and sampling conditions.
At least three sampling locations are required to identify a trend. This means that even with weekly testing, approximately three weeks of data will be needed to consistently confirm a change in pathogen levels.
The guidelines also prohibit the use of wastewater surveillance data to identify any individual or family. Findings from areas with populations of fewer than 3,000 people or from a single institution must not be made public.
With standardised sampling, laboratory testing and mandatory reporting timelines, the new national framework seeks to strengthen India's ability to detect infectious disease threats early while ensuring that wastewater surveillance data is used responsibly and without compromising individual privacy.

Comment List